NOBEL BIOCARE U.K. LIMITED

1. NOBEL BIOCARE U.K. LIMITED 1996-05-09 → present
2. NOBELPHARMA U.K. LIMITED 1988-10-03 → 1996-05-09
3. AUSTENAL DENTAL PRODUCTS LIMITED 1984-06-27 → 1988-10-03

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Having considered the Company's funding position and financial projections, the Directors have concluded these conditions do not indicate a significant doubt over the Company's ability to continue as a going concern. At the time of approving the Financial Statements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”

Group structure

1. NOBEL BIOCARE U.K. LIMITED · parent
   1. Nobel Biocare Mexico, S.A de CV 0.002% · Mexico

Significant events

• “There have been no significant events affecting the Company since the year end.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -5.2%

  £10,826,635 → £10,264,907

• Cash

  +110.3%

  £1,117,424 → £2,349,941

• Net assets

  +7.5%

  £3,171,651 → £3,409,943

• Employees

  -10%

  30 → 27

• Operating profit

  +11.4%

  £224,484 → £250,180

• Profit before tax

  +25.2%

  £230,302 → £288,261

• Wages

  +0.6%

  £2,113,705 → £2,125,915

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers